Dr. Steinle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E Micheltorena St
Ste A
Santa Barbara, CA 93103Phone+1 805-963-1648Fax+1 805-965-5214
Education & Training
Cleveland Clinic FoundationFellowship, Surgical Retina and Vitreous, 2009 - 2011
University of Kentucky College of MedicineResidency, Ophthalmology, 2006 - 2009- University of Kentucky College of Medicine (Bowling Green)Internship, Transitional Year, 2005 - 2006
University of South Dakota, Sanford School of MedicineClass of 2005
Certifications & Licensure
CA State Medical License 2011 - 2025
SD State Medical License Active through 2025
WY State Medical License 2021 - 2025
KY State Medical License 2020 - 2022
OH State Medical License 2009 - 2012- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Analysis of Aqueous and Vitreous Humor Start of enrollment: 2015 Jul 01
- Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab Start of enrollment: 2015 Mar 13
- INtravitreal and Aqueous Dexamethasone Levels After DEXtenza Start of enrollment: 2021 Mar 01
Publications & Presentations
PubMed
- 6 citationsRetinal infiltrates secondary to metastatic squamous cell carcinoma masquerading as infectious retinitis.Rishi P Singh, Nathan Steinle, Rumneek Bedi, Peter K. Kaiser, Careen Y. Lowder
Retinal Cases & Brief Reports. 2014-10-01 - 279 citationsSystemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMDRobert L. Avery, Alessandro A. Castellarin, Nathan Steinle, Dilsher S. Dhoot, Dante J. Pieramici
The British Journal of Ophthalmology. 2014-12-01 - 35 citationsPhase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular Degeneration.Pravin U. Dugel, David S. Boyer, Andrew N. Antoszyk, Nathan C. Steinle, Michael P. Varenhorst
Ophthalmology. Retina. 2020-03-01
Press Mentions
Research Promises Better Diabetic Retinopathy ManagementAugust 16th, 2024
July 29, 2018July 29th, 2018- SYFOVRE® (Pegcetacoplan Injection) Continued to Demonstrate Increasing Treatment Effects over 30 Months in Patients with Geographic Atrophy (GA)July 31st, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
